EP3277831A4 - Système de biocapteur pour la détection rapide d'analytes - Google Patents

Système de biocapteur pour la détection rapide d'analytes Download PDF

Info

Publication number
EP3277831A4
EP3277831A4 EP16774179.2A EP16774179A EP3277831A4 EP 3277831 A4 EP3277831 A4 EP 3277831A4 EP 16774179 A EP16774179 A EP 16774179A EP 3277831 A4 EP3277831 A4 EP 3277831A4
Authority
EP
European Patent Office
Prior art keywords
analytes
rapid detection
biosensor system
biosensor
rapid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP16774179.2A
Other languages
German (de)
English (en)
Other versions
EP3277831A2 (fr
Inventor
Thomas J. Zupancic
Lingchun ZENG
Srikanth Vedamoorthy
Joel S. LWANDE
Joseph D. Kittle
Min MO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fundamental Solutions Corp
Original Assignee
Fundamental Solutions Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundamental Solutions Corp filed Critical Fundamental Solutions Corp
Priority to EP18209257.7A priority Critical patent/EP3470527A1/fr
Priority to EP18180724.9A priority patent/EP3404411A3/fr
Priority to EP18180727.2A priority patent/EP3404412A3/fr
Priority to EP18180720.7A priority patent/EP3404410B1/fr
Publication of EP3277831A2 publication Critical patent/EP3277831A2/fr
Publication of EP3277831A4 publication Critical patent/EP3277831A4/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/22—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a Strep-tag
EP16774179.2A 2015-03-31 2016-03-31 Système de biocapteur pour la détection rapide d'analytes Pending EP3277831A4 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP18209257.7A EP3470527A1 (fr) 2015-03-31 2016-03-31 Protéine de fusion fcgammari-igm
EP18180724.9A EP3404411A3 (fr) 2015-03-31 2016-03-31 Système de biocapteur pour la détection rapide d'analytes
EP18180727.2A EP3404412A3 (fr) 2015-03-31 2016-03-31 Système de biocapteur pour la détection rapide d'analytes
EP18180720.7A EP3404410B1 (fr) 2015-03-31 2016-03-31 Système de biocapteur pour la détection rapide d'analytes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562140920P 2015-03-31 2015-03-31
PCT/US2016/025219 WO2016161088A2 (fr) 2015-03-31 2016-03-31 Système de biocapteur pour la détection rapide d'analytes

Related Child Applications (8)

Application Number Title Priority Date Filing Date
EP18180727.2A Division EP3404412A3 (fr) 2015-03-31 2016-03-31 Système de biocapteur pour la détection rapide d'analytes
EP18180727.2A Division-Into EP3404412A3 (fr) 2015-03-31 2016-03-31 Système de biocapteur pour la détection rapide d'analytes
EP18180724.9A Division-Into EP3404411A3 (fr) 2015-03-31 2016-03-31 Système de biocapteur pour la détection rapide d'analytes
EP18180724.9A Division EP3404411A3 (fr) 2015-03-31 2016-03-31 Système de biocapteur pour la détection rapide d'analytes
EP18180720.7A Division-Into EP3404410B1 (fr) 2015-03-31 2016-03-31 Système de biocapteur pour la détection rapide d'analytes
EP18180720.7A Division EP3404410B1 (fr) 2015-03-31 2016-03-31 Système de biocapteur pour la détection rapide d'analytes
EP18209257.7A Division-Into EP3470527A1 (fr) 2015-03-31 2016-03-31 Protéine de fusion fcgammari-igm
EP18209257.7A Division EP3470527A1 (fr) 2015-03-31 2016-03-31 Protéine de fusion fcgammari-igm

Publications (2)

Publication Number Publication Date
EP3277831A2 EP3277831A2 (fr) 2018-02-07
EP3277831A4 true EP3277831A4 (fr) 2019-01-09

Family

ID=57007336

Family Applications (5)

Application Number Title Priority Date Filing Date
EP18180727.2A Pending EP3404412A3 (fr) 2015-03-31 2016-03-31 Système de biocapteur pour la détection rapide d'analytes
EP16774179.2A Pending EP3277831A4 (fr) 2015-03-31 2016-03-31 Système de biocapteur pour la détection rapide d'analytes
EP18180720.7A Active EP3404410B1 (fr) 2015-03-31 2016-03-31 Système de biocapteur pour la détection rapide d'analytes
EP18180724.9A Pending EP3404411A3 (fr) 2015-03-31 2016-03-31 Système de biocapteur pour la détection rapide d'analytes
EP18209257.7A Withdrawn EP3470527A1 (fr) 2015-03-31 2016-03-31 Protéine de fusion fcgammari-igm

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP18180727.2A Pending EP3404412A3 (fr) 2015-03-31 2016-03-31 Système de biocapteur pour la détection rapide d'analytes

Family Applications After (3)

Application Number Title Priority Date Filing Date
EP18180720.7A Active EP3404410B1 (fr) 2015-03-31 2016-03-31 Système de biocapteur pour la détection rapide d'analytes
EP18180724.9A Pending EP3404411A3 (fr) 2015-03-31 2016-03-31 Système de biocapteur pour la détection rapide d'analytes
EP18209257.7A Withdrawn EP3470527A1 (fr) 2015-03-31 2016-03-31 Protéine de fusion fcgammari-igm

Country Status (9)

Country Link
EP (5) EP3404412A3 (fr)
JP (1) JP6828005B2 (fr)
KR (1) KR102540406B1 (fr)
CN (1) CN107429286A (fr)
CA (1) CA2982133C (fr)
ES (1) ES2893879T3 (fr)
IL (1) IL254687B2 (fr)
RU (1) RU2717658C2 (fr)
WO (1) WO2016161088A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10613083B2 (en) 2016-12-22 2020-04-07 Fundamental Solutions Corporation Universal biosensor system for analyte detection
KR102222731B1 (ko) * 2016-12-22 2021-03-05 펀다멘탈 솔류션스 코포레이션 분석물 검출을 위한 범용 바이오센서 시스템
WO2019076262A1 (fr) * 2017-10-18 2019-04-25 深圳华大生命科学研究院 Biocapteur permettant la détection d'un composé moléculaire cible et système comprenant un biocapteur
EP3765093A4 (fr) * 2018-03-15 2021-12-08 Fundamental Solutions Corporation Système complexe de récepteurs d'immunocytes programmable
EP3870973A4 (fr) * 2018-10-25 2022-04-13 The State of Israel, Ministry of Agriculture and Rural Development, Agricultural Research Organization (ARO) (Volcani Center) Moyen et procédé d'analyse hors laboratoire d'échantillons liquides
CN113214374B (zh) * 2020-02-06 2022-08-26 深圳华大基因股份有限公司 一种包虫病新抗原Cystatin蛋白
CN113050547B (zh) * 2021-03-04 2022-03-25 宏晶微电子科技股份有限公司 测试激励生成方法、测试方法、电子设备、存储介质
KR102625649B1 (ko) 2022-12-13 2024-01-17 주식회사 다이아슈어바이오 핵산 증폭 기술에서 신호전달물질을 이용한 핵산의 전기화학적 검출방법

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002020038A2 (fr) * 2000-09-06 2002-03-14 Pharmexa A/S Procede de regulation negative d'ige
WO2013019615A2 (fr) * 2011-07-29 2013-02-07 The Trustees Of The University Of Pennsylvania Récepteurs de commutation par costimulation
WO2013116287A1 (fr) * 2012-01-31 2013-08-08 Genentech, Inc. ANTICORPS ANTI-IgE SE LIANT À M1' ET LEURS PROCÉDÉS D'UTILISATION

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020168367A1 (en) * 2000-04-28 2002-11-14 Planet Biotechnology Incorporated Novel immunoadhesins for treating and preventing viral and bacterial diseases
CN101551337B (zh) * 2001-02-07 2013-06-19 麻省理工学院 光电子探测系统
US8216797B2 (en) * 2001-02-07 2012-07-10 Massachusetts Institute Of Technology Pathogen detection biosensor
IL158788A0 (en) * 2001-05-09 2004-05-12 Axis Shield Asa Assay system
US20050202442A1 (en) * 2003-12-15 2005-09-15 Morris David W. Novel therapeutic targets in cancer
RU2318197C2 (ru) * 2002-05-20 2008-02-27 Нортроп Грумман Корпорейшен Автоматическая система и способ обнаружения точечного источника биологического агента
US20070003561A1 (en) * 2003-07-08 2007-01-04 Sorensen Anders P Binding member towards pneumococcus surface adhesin a protein (psaa)
JP2009503115A (ja) * 2005-08-03 2009-01-29 アールキュー バイオサイエンス インク ＩｇＡ及びＩｇＭを媒介する腎臓症を診断するための方法及び組成物
BRPI0619234A2 (pt) * 2005-11-30 2011-11-08 Massachusetts Inst Technology método e aparelho para detectar antìgeno solúvel, método e aparelho para detectar partìcula alvo e método para identificar uma patogenia em plantas
GB0614780D0 (en) * 2006-07-25 2006-09-06 Ucb Sa Biological products
SI2519543T1 (sl) * 2009-12-29 2016-08-31 Emergent Product Development Seattle, Llc Beljakovine, ki se vežejo s heterodimeri in njihova uporaba
TW201302971A (zh) 2011-06-28 2013-01-16 Murata Manufacturing Co 絕緣性接著層組合物、蓄電裝置用元件、蓄電裝置、及其等之製造方法
US9023640B2 (en) * 2011-12-13 2015-05-05 Fundamental Solutions Corporation Device for rapid detection of infectious agents
WO2014160235A1 (fr) * 2013-03-13 2014-10-02 Applied Biomolecular Technologies Procédé pour l'amplification du signal dans un système à base d'un biocapteur pour la détection rapide d'agents infectieux
WO2014160140A1 (fr) * 2013-03-13 2014-10-02 Applied Biomolecular Technologies Système pour la détection rapide d'agents infectieux à l'aide d'un biocapteur à base d'hybridome

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002020038A2 (fr) * 2000-09-06 2002-03-14 Pharmexa A/S Procede de regulation negative d'ige
WO2013019615A2 (fr) * 2011-07-29 2013-02-07 The Trustees Of The University Of Pennsylvania Récepteurs de commutation par costimulation
WO2013116287A1 (fr) * 2012-01-31 2013-08-08 Genentech, Inc. ANTICORPS ANTI-IgE SE LIANT À M1' ET LEURS PROCÉDÉS D'UTILISATION

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
A LOSKOG ET AL: "Addition of the CD28 signaling domain to chimeric T-cell receptors enhances chimeric T-cell resistance to T regulatory cells", LEUKEMIA, vol. 20, no. 10, 17 August 2006 (2006-08-17), pages 1819 - 1828, XP055109421, ISSN: 0887-6924, DOI: 10.1038/sj.leu.2404366 *
DANIEL DEMONTE ET AL: "Expression and purification of soluble monomeric streptavidin in Escherichia coli", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, vol. 98, no. 14, 1 July 2014 (2014-07-01), DE, pages 6285 - 6295, XP055457564, ISSN: 0175-7598, DOI: 10.1007/s00253-014-5682-y *
DANIEL M. CZAJKOWSKY ET AL: "Fc-fusion proteins: new developments and future perspectives", EMBO MOLECULAR MEDICINE, vol. 4, no. 10, 26 July 2012 (2012-07-26), pages 1015 - 1028, XP055160259, ISSN: 1757-4676, DOI: 10.1002/emmm.201201379 *
DAVID L PORTER ET AL: "Chimeric Antigen Receptor Therapy for B-cell Malignancies", JOURNAL OF CANCER, vol. 2042127, 1 January 2011 (2011-01-01), AU, pages 331, XP055247868, ISSN: 1837-9664, DOI: 10.7150/jca.2.331 *
JONATHAN T. SOCKOLOSKY ET AL: "Fusion of a Short Peptide that Binds Immunoglobulin G to a Recombinant Protein Substantially Increases Its Plasma Half-Life in Mice", PLOS ONE, vol. 9, no. 7, 24 July 2014 (2014-07-24), pages e102566, XP055490311, DOI: 10.1371/journal.pone.0102566 *
KOK HONG LIM ET AL: "Stable, high-affinity streptavidin monomer for protein labeling and monovalent biotin detection", BIOTECHNOLOGY AND BIOENGINEERING, vol. 110, no. 1, 1 January 2013 (2013-01-01), US, pages 57 - 67, XP055457562, ISSN: 0006-3592, DOI: 10.1002/bit.24605 *
WEONU CHOE ET AL: "Fc-Binding Ligands of Immunoglobulin G: An Overview of High Affinity Proteins and Peptides", MATERIALS, vol. 9, no. 12, 8 December 2016 (2016-12-08), pages 994, XP055490322, DOI: 10.3390/ma9120994 *

Also Published As

Publication number Publication date
IL254687A0 (en) 2017-11-30
EP3404412A2 (fr) 2018-11-21
EP3404410A3 (fr) 2019-01-30
CA2982133C (fr) 2022-05-03
EP3404411A3 (fr) 2019-02-13
EP3404412A3 (fr) 2019-02-13
EP3404411A2 (fr) 2018-11-21
RU2717658C2 (ru) 2020-03-24
ES2893879T3 (es) 2022-02-10
WO2016161088A3 (fr) 2016-11-24
CA2982133A1 (fr) 2016-10-06
EP3470527A1 (fr) 2019-04-17
RU2017129911A (ru) 2019-05-06
CN107429286A (zh) 2017-12-01
EP3277831A2 (fr) 2018-02-07
KR102540406B1 (ko) 2023-06-09
IL254687B2 (en) 2024-01-01
EP3404410A2 (fr) 2018-11-21
IL254687B1 (en) 2023-09-01
EP3404410B1 (fr) 2021-07-14
RU2017129911A3 (fr) 2020-01-27
JP2018516590A (ja) 2018-06-28
JP6828005B2 (ja) 2021-02-10
WO2016161088A2 (fr) 2016-10-06
KR20170132861A (ko) 2017-12-04

Similar Documents

Publication Publication Date Title
EP3592768A4 (fr) Détection d'analytes
EP3397398A4 (fr) Couche de biointerface pour détecteurs d'analyte
EP3425055A4 (fr) Réactif de détection/diagnostic moléculaire concernant une tumeur
EP3040025A4 (fr) Système de détection d'analyte
EP3665187A4 (fr) Procédés de dosage pour la détection améliorée d'analytes
EP3149465A4 (fr) Capteur électrochimique pour la détection d'analyte
EP3314530A4 (fr) Système de détection d'émotion
IL254687B1 (en) A bio-sensor system for rapid identification of an analyte
EP3448244A4 (fr) Biocapteurs eab pour détecter des analytes de transpiration
EP3180613A4 (fr) Capteur d'analyte continu
EP3215836A4 (fr) Dispositifs, systèmes et procédés pour détecter des analytes
EP3292395A4 (fr) Procédés et systèmes de détection d'analytes
EP3236243A4 (fr) Système d'analyse d'échantillons de dosage transférés en ligne
EP3090252A4 (fr) Procédés et systèmes de détection électrochimique d'analytes
EP3588075A4 (fr) Biocapteur à haute sensibilité
EP3117203A4 (fr) Détection de substance ou de contamination
HK1248818A1 (zh) 改進的生物傳感器系統分析物測量
EP3598129A4 (fr) Système de détection d'échantillon
EP3704466A4 (fr) Procédé de détection d'analyte
EP3454056A4 (fr) Biocapteur
AU2018290327A1 (en) Analyte sensor
EP3546590A4 (fr) Procédé de détection d'acide nucléique
IL267568A (en) A universal biosensor system for analytical detection
EP3353697A4 (fr) Analyse de multiples ensembles de données pour déterminer la présence ou l'absence d'analyte cible
EP3376208A4 (fr) Système de détection d'échantillon optique

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20170907

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MO, MIN

Inventor name: ZUPANCIC, THOMAS, J.

Inventor name: LWANDE, JOEL, S.

Inventor name: ZENG, LINGCHUN

Inventor name: VEDAMOORTHY, SRIKANTH

Inventor name: KITTLE, JOSEPH, D.

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/554 20060101ALI20180711BHEP

Ipc: G01N 33/569 20060101ALI20180711BHEP

Ipc: C12Q 1/04 20060101AFI20180711BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20181211

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/04 20060101AFI20181205BHEP

Ipc: G01N 33/554 20060101ALI20181205BHEP

Ipc: G01N 33/569 20060101ALI20181205BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20210122

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS